Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

78.75M

Market cap78.75M

Price-Earnings ratio

-2.35

Price-Earnings ratio-2.35

Dividend yield

—

Dividend yield—

Average volume

733.08K

Average volume733.08K

High today

$0.5532

High today$0.5532

Low today

$0.52

Low today$0.52

Open price

$0.5475

Open price$0.5475

Volume

759.60K

Volume759.60K

52 Week high

$1.75

52 Week high$1.75

52 Week low

$0.45

52 Week low$0.45

Veru

Why Robinhood?

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Show more

VERU Key Statistics

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.